IgA nephropathy diagnosis is hindered by nonspecific symptoms and the necessity of a kidney biopsy for confirmation.
Misdiagnosis or delayed diagnosis arises from symptom overlap with other renal conditions, such as hematuria and proteinuria.
Limited awareness among healthcare providers and variability in disease presentation contribute to diagnostic challenges.
Enhancing awareness, access to diagnostic tools, and developing non-invasive biomarkers are crucial for improving early detection and patient outcomes.
SHOW MORE
Panelists discuss how misdiagnosis and delayed diagnosis of IgA nephropathy occur, highlighting the primary barriers to timely detection and strategies to overcome these challenges.